Deerfield Management Company »

Ambac Finl shares owned by Deerfield Management Company

Quarter-by-quarter ownership of Ambac Finl (AMBC) shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in Ambac Finl

Tip: Access up to 7 years of quarterly data

All positions including Ambac Finl held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ambac Finl by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $209k 13k 16.48

More positions owned by Deerfield Management Company

Nuvalent Inc-a (NUVL)
Glaukos Corp Note 2.750% 6/1 (Principal)
Viatris (VTRS)
Invitae Corp Debt 4.500% 3/1 (Principal)
Natera Note 2.250% 5/0 (Principal)
Catalyst Pharmaceutical Partners (CPRX)
Centene Corporation (CNC)
Brookdale Sr Living Note 2.000%10/1 (Principal)
Insmed Note 1.750% 1/1 (Principal)
Neurocrine Biosciences (NBIX)
Accolade Note 0.500% 4/0 (Principal)
Oscar Health Cl A (OSCR)
Owens & Minor (OMI)
Adapthealth Corp Common Stock (AHCO)
Springworks Therapeutics (SWTX)

View all positions for Deerfield Management Company

Top funds holding Ambac Finl

Vanguard Group
Dimensional Fund Advisors
Bracebridge Capital
Deutsche Bank Aktiengesellschaft
Citadel Advisors
Goldman Sachs Group
Charles Schwab Investment Management
Repertoire Partners
Walleye Trading
D. E. Shaw & Co
Jupiter Asset Management
Bank of New York Mellon
Hotchkis and Wiley Capital Management
AQR Capital Management
Hsbc Holdings

View all funds holding Ambac Finl